Anti-PRP17/ CDC40/ EHB3 functional antibody

Anti-PRP17/ CDC40/ EHB3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CDC40/CDC40 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1587-Ab-1/ GM-Tg-hg-SE1587-Ab-2Anti-Human CDC40 monoclonal antibodyHuman
GM-Tg-rg-SE1587-Ab-1/ GM-Tg-rg-SE1587-Ab-2Anti-Rat CDC40 monoclonal antibodyRat
GM-Tg-mg-SE1587-Ab-1/ GM-Tg-mg-SE1587-Ab-2Anti-Mouse CDC40 monoclonal antibodyMouse
GM-Tg-cynog-SE1587-Ab-1/ GM-Tg-cynog-SE1587-Ab-2Anti-Cynomolgus/ Rhesus macaque CDC40 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1587-Ab-1/ GM-Tg-felg-SE1587-Ab-2Anti-Feline CDC40 monoclonal antibodyFeline
GM-Tg-cang-SE1587-Ab-1/ GM-Tg-cang-SE1587-Ab-2Anti-Canine CDC40 monoclonal antibodyCanine
GM-Tg-bovg-SE1587-Ab-1/ GM-Tg-bovg-SE1587-Ab-2Anti-Bovine CDC40 monoclonal antibodyBovine
GM-Tg-equg-SE1587-Ab-1/ GM-Tg-equg-SE1587-Ab-2Anti-Equine CDC40 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1587-Ab-1/ GM-Tg-hg-SE1587-Ab-2; GM-Tg-rg-SE1587-Ab-1/ GM-Tg-rg-SE1587-Ab-2;
GM-Tg-mg-SE1587-Ab-1/ GM-Tg-mg-SE1587-Ab-2; GM-Tg-cynog-SE1587-Ab-1/ GM-Tg-cynog-SE1587-Ab-2;
GM-Tg-felg-SE1587-Ab-1/ GM-Tg-felg-SE1587-Ab-2; GM-Tg-cang-SE1587-Ab-1/ GM-Tg-cang-SE1587-Ab-2;
GM-Tg-bovg-SE1587-Ab-1/ GM-Tg-bovg-SE1587-Ab-2; GM-Tg-equg-SE1587-Ab-1/ GM-Tg-equg-SE1587-Ab-2
Products NameAnti-CDC40 monoclonal antibody
Formatmab
Target NameCDC40
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CDC40 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1587-Ag-1Recombinant multi-species PRP17/ CDC40/ EHB3 protein


    Target information

    Target IDGM-SE1587
    Target NameCDC40
    Gene ID51362,71713,361859,697474,475025,101080793,514003,100066771
    Gene Symbol and Synonyms1200003H23Rik,CDC40,EHB3,PCH15,PRP17,PRPF17
    Uniprot AccessionO60508
    Uniprot Entry NamePRP17_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168438
    Target ClassificationN/A

    The target: CDC40, gene name: CDC40, also named as EHB3, PRP17, PRPF17. Pre-mRNA splicing occurs in two sequential transesterification steps. The protein encoded by this gene is found to be essential for the catalytic step II in pre-mRNA splicing process. It is found in the spliceosome, and contains seven WD repeats, which function in protein-protein interactions. This protein has a sequence similarity to yeast Prp17 protein, which functions in two different cellular processes: pre-mRNA splicing and cell cycle progression. It suggests that this protein may play a role in cell cycle progression. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.